Incentives for local pharma, health-care sectors urged | Inquirer Business
TO ATTRACT MORE INVESTORS, SAYS PHAP

Incentives for local pharma, health-care sectors urged

/ 02:04 AM February 27, 2023

The Pharmaceutical and Healthcare Association of the Philippines (PHAP) has urged the government to put in place an incentives system specific to the local industry, as well as improve the ease of doing business in the country to entice more investors in this sector.

“We have to learn from our neighboring countries what are the best practices, what makes it easy, how easy it is for us to set up a business, how the government is also incentivizing, building manufacturing sites in the Philippines,” PHAP president Diana Edralin told reporters in a recent interview.

“One of the requests that we want is some predictability in terms of the regulatory approval process,” she said, specifying the challenges they are experiencing when it comes to obtaining local licenses and permits.

Article continues after this advertisement

The PHAP official said that tax incentivization is but one element in the overall effort to attract more investments to develop the pharmaceutical sector and health-care industry.

FEATURED STORIES

“The tax incentivization is only one aspect. Can I set up a site in two weeks? Will I get my permit in two weeks’ time? The regulatory process is also critical,” she said.

Edralin said that it used to take two to three years to get regulatory approval for their products from the Food and Drug Administration, but was since cut down to more reasonable time frames.

Article continues after this advertisement

With the reliance-based regulatory system adopted by the Philippine regulator in 2020, the PHAP official said they were able to trim this process down to 48 days for some drugs.

Article continues after this advertisement

She said that under the system, drugs that are already approved in another country get a faster approval process through coordination between their respective regulatory agencies.

Article continues after this advertisement

In November of last year, the Philippine Pharmaceutical Manufacturers Association (PPMA) said that only 32 percent of pharmaceutical products being sold in the Philippines are locally manufactured, meaning that the majority of the medicines bought in local stores are imported.

PPMA president Higinio Porte Jr., said that these are mostly imported from India and China.

Article continues after this advertisement

He said further that local manufacturers are losing in price competitiveness with products from these two countries, citing that more investments and stronger government support are needed to reverse the situation. INQ

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Business

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.